Challenges of managing the asymptomatic carriers of SARS-CoV-2
Identifieur interne : 000860 ( Main/Curation ); précédent : 000859; suivant : 000861Challenges of managing the asymptomatic carriers of SARS-CoV-2
Auteurs : Farid RahimiSource :
- Travel Medicine and Infectious Disease [ 1477-8939 ] ; 2020.
Abstract
After an outbreak in Wuhan, China, a growing number of countries are now suffering from an epidemic by SARS-CoV-2, which causes COVID-19. Undoubtedly, reports of the skyrocketing global spread of COVID-19 has shocked people globally, from Japan to the United States.Presently, the World Health Organization indicates that fatality due to COVID-19 is about 2%, inferring that many positive subjects may potentially overcome the illness with mild influenza-like symptoms and no need for hospitalization at intensive-care units. Because COVID-19 is completely new to the human immune system, many throughout the world are likely vulnerable to becoming sick after their initial exposure to SARSCoV-2. Besides hospitalized cases, many individuals are likely asymptomatic but potentially carry the virus. While our knowledge about carriers and their virus shedding is deficient, some studies modelling the viral transmission have considered the potential contribution of the asymptomatic carriers. Protocols for managing asymptomatic cases, for example for controlling them to restrict their contact with healthy people at public places or private residences, have not been established.In-house quarantine may as well be applicable to asymptomatic cases if they could be identified and diagnosed. Presumably now, the asymptomatic subjects potentially contribute to the transmission of COVID-19 without their knowledge, intention or being diagnosed as carriers. Thus, managing the asymptomatic cases, who can carry and likely transmit the virus, is a major healthcare challenge while a pandemic is looming.
Url:
DOI: 10.1016/j.tmaid.2020.101677
PubMed: NONE
PubMed Central: 7165291
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000B29
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000B29
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000345
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003D49
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :003D49
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003D49
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :000860
Links to Exploration step
PMC:7165291Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Challenges of managing the asymptomatic carriers of SARS-CoV-2</title>
<author><name sortKey="Rahimi, Farid" sort="Rahimi, Farid" uniqKey="Rahimi F" first="Farid" last="Rahimi">Farid Rahimi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7165291</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165291</idno>
<idno type="RBID">PMC:7165291</idno>
<idno type="doi">10.1016/j.tmaid.2020.101677</idno>
<idno type="pmid">NONE</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">000B29</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B29</idno>
<idno type="wicri:Area/Pmc/Curation">000B29</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B29</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000345</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000345</idno>
<idno type="wicri:Area/Ncbi/Merge">003D49</idno>
<idno type="wicri:Area/Ncbi/Curation">003D49</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003D49</idno>
<idno type="wicri:doubleKey">1477-8939:2020:Rahimi F:challenges:of:managing</idno>
<idno type="wicri:Area/Main/Merge">000860</idno>
<idno type="wicri:Area/Main/Curation">000860</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Challenges of managing the asymptomatic carriers of SARS-CoV-2</title>
<author><name sortKey="Rahimi, Farid" sort="Rahimi, Farid" uniqKey="Rahimi F" first="Farid" last="Rahimi">Farid Rahimi</name>
</author>
</analytic>
<series><title level="j">Travel Medicine and Infectious Disease</title>
<idno type="ISSN">1477-8939</idno>
<idno type="eISSN">1873-0442</idno>
<imprint><date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>After an outbreak in Wuhan, China, a growing number of countries are now suffering from an epidemic by SARS-CoV-2, which causes COVID-19. Undoubtedly, reports of the skyrocketing global spread of COVID-19 has shocked people globally, from Japan to the United States.Presently, the World Health Organization indicates that fatality due to COVID-19 is about 2%, inferring that many positive subjects may potentially overcome the illness with mild influenza-like symptoms and no need for hospitalization at intensive-care units. Because COVID-19 is completely new to the human immune system, many throughout the world are likely vulnerable to becoming sick after their initial exposure to SARSCoV-2. Besides hospitalized cases, many individuals are likely asymptomatic but potentially carry the virus. While our knowledge about carriers and their virus shedding is deficient, some studies modelling the viral transmission have considered the potential contribution of the asymptomatic carriers. Protocols for managing asymptomatic cases, for example for controlling them to restrict their contact with healthy people at public places or private residences, have not been established.In-house quarantine may as well be applicable to asymptomatic cases if they could be identified and diagnosed. Presumably now, the asymptomatic subjects potentially contribute to the transmission of COVID-19 without their knowledge, intention or being diagnosed as carriers. Thus, managing the asymptomatic cases, who can carry and likely transmit the virus, is a major healthcare challenge while a pandemic is looming.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Worldometer" uniqKey="Worldometer">worldometer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Huang, C" uniqKey="Huang C">C. Huang</name>
</author>
<author><name sortKey="Wang, Y" uniqKey="Wang Y">Y. Wang</name>
</author>
<author><name sortKey="Li, X" uniqKey="Li X">X. Li</name>
</author>
<author><name sortKey="Ren, L" uniqKey="Ren L">L. Ren</name>
</author>
<author><name sortKey="Zhao, J" uniqKey="Zhao J">J. Zhao</name>
</author>
<author><name sortKey="Hu, Y" uniqKey="Hu Y">Y. Hu</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fisher, D" uniqKey="Fisher D">D. Fisher</name>
</author>
<author><name sortKey="Heymann, D" uniqKey="Heymann D">D. Heymann</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chen, T M" uniqKey="Chen T">T.M. Chen</name>
</author>
<author><name sortKey="Rui, J" uniqKey="Rui J">J. Rui</name>
</author>
<author><name sortKey="Wang, Q P" uniqKey="Wang Q">Q.P. Wang</name>
</author>
<author><name sortKey="Zhao, Z Y" uniqKey="Zhao Z">Z.Y. Zhao</name>
</author>
<author><name sortKey="Cui, J A" uniqKey="Cui J">J.A. Cui</name>
</author>
<author><name sortKey="Yin, L" uniqKey="Yin L">L. Yin</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000860 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000860 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Curation |type= RBID |clé= PMC:7165291 |texte= Challenges of managing the asymptomatic carriers of SARS-CoV-2 }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:NONE" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |